Assessing the Effect of Ketamine on Suprarefractory Status Epilepticus Requires Appropriately Designed Cohort Studies
J Pediatr Pharmacol Ther
.
2023;28(6):585-586.
doi: 10.5863/1551-6776-28.6.585.
Epub 2023 Oct 28.
Authors
Josef Finsterer
1
,
Craig A Press
2
,
Mackenzie N DeVine
3
,
Sharon E Gordon
3
Affiliations
1
Neurology & Neurophysiology Center, Vienna, Austria.
2
Department of Pediatrics and Neurology (CAP), University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
3
Department of Pharmacy (MND, SEG), Children's Hospital Colorado, Aurora, CO.
PMID:
38130346
PMCID:
PMC10731937
DOI:
10.5863/1551-6776-28.6.585
No abstract available